Implants inserted with graftless osteotome sinus floor elevation - A 5-year post-loading retrospective study
Standard
Implants inserted with graftless osteotome sinus floor elevation - A 5-year post-loading retrospective study. / Zill, Alexander; Precht, Clarissa; Beck-Broichsitter, Benedicta; Sehner, Susanne; Smeets, Ralf; Heiland, Max; Rendenbach, Carsten; Henningsen, Anders.
in: EUR J ORAL IMPLANTOL, Jahrgang 9, Nr. 3, 2016, S. 277-289.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Implants inserted with graftless osteotome sinus floor elevation - A 5-year post-loading retrospective study
AU - Zill, Alexander
AU - Precht, Clarissa
AU - Beck-Broichsitter, Benedicta
AU - Sehner, Susanne
AU - Smeets, Ralf
AU - Heiland, Max
AU - Rendenbach, Carsten
AU - Henningsen, Anders
PY - 2016
Y1 - 2016
N2 - PURPOSE: To report the outcome of graftless osteotome sinus floor elevation (OSFE) in order to evaluate whether apical bone gain depends on the initial residual bone height and whether the initial residual bone height has an influence on the amount of marginal bone loss. Furthermore the study aimed to assess if perforations of the Schneiderian membrane or residual bone height are potential predictors of implant survival.MATERIALS AND METHODS: In this retrospective study all patients were included who were treated between 2001 and 2010 and received dental implants in combination with OSFE in a private practice. Patients having 1 to 11 mm of residual bone height were subjected to crestal sinus lift elevation. One hundred and thirteen patients with 233 implants were included in this study. The follow-up period was 5-years post-loading for all patients. The average initial bone level height was 5.9 ± 1.7 mm. No bone graft or substitute material was used. All implants healed transgingivally and were loaded 3 months after insertion. Outcome measures were prosthetic success, implant success, complications, radiographic crestal bone level changes and apical (sinus floor) bone height.RESULTS: Sixty-three patients dropped out during the 5-year post-loading follow-up. Seven implants in 7 patients failed. Implant survival rate 5 years after loading was 93.8% at patient level. Implants succeeded in 92.7% of all cases. In six patients (5.3%), prostheses failed and had to be remade. Minor complications like small ceramic fractures and loosening of prosthetics were observed in seven patients (6.2%). Average marginal bone loss at 5 years of follow-up was 0.5 ± 0.8 mm per patient. No correlation was found between marginal bone loss and initial residual bone height. Average gained bone height was 4.5 ± 1.4 mm after 5 years of loading. We found a significantly negative linear correlation for apical bone gain depending on the baseline bone level (P < 0.001). The apical bone gain was higher in cases with less residual bone.CONCLUSIONS: Implants after graftless osteotome sinus floor elevation showed excellent survival and success rates after 5 years of loading. Apical gain of newly formed bone was positively correlated with the initial bone height showing a statistical significance. However, initial residual bone height is also a predictor for implant survival, i.e. survival increases by 1.6 times with every additional millimetre of initial residual bone height. Conflict-of-interest statement: All authors declare that they have neither financial nor non-financial competing interests.
AB - PURPOSE: To report the outcome of graftless osteotome sinus floor elevation (OSFE) in order to evaluate whether apical bone gain depends on the initial residual bone height and whether the initial residual bone height has an influence on the amount of marginal bone loss. Furthermore the study aimed to assess if perforations of the Schneiderian membrane or residual bone height are potential predictors of implant survival.MATERIALS AND METHODS: In this retrospective study all patients were included who were treated between 2001 and 2010 and received dental implants in combination with OSFE in a private practice. Patients having 1 to 11 mm of residual bone height were subjected to crestal sinus lift elevation. One hundred and thirteen patients with 233 implants were included in this study. The follow-up period was 5-years post-loading for all patients. The average initial bone level height was 5.9 ± 1.7 mm. No bone graft or substitute material was used. All implants healed transgingivally and were loaded 3 months after insertion. Outcome measures were prosthetic success, implant success, complications, radiographic crestal bone level changes and apical (sinus floor) bone height.RESULTS: Sixty-three patients dropped out during the 5-year post-loading follow-up. Seven implants in 7 patients failed. Implant survival rate 5 years after loading was 93.8% at patient level. Implants succeeded in 92.7% of all cases. In six patients (5.3%), prostheses failed and had to be remade. Minor complications like small ceramic fractures and loosening of prosthetics were observed in seven patients (6.2%). Average marginal bone loss at 5 years of follow-up was 0.5 ± 0.8 mm per patient. No correlation was found between marginal bone loss and initial residual bone height. Average gained bone height was 4.5 ± 1.4 mm after 5 years of loading. We found a significantly negative linear correlation for apical bone gain depending on the baseline bone level (P < 0.001). The apical bone gain was higher in cases with less residual bone.CONCLUSIONS: Implants after graftless osteotome sinus floor elevation showed excellent survival and success rates after 5 years of loading. Apical gain of newly formed bone was positively correlated with the initial bone height showing a statistical significance. However, initial residual bone height is also a predictor for implant survival, i.e. survival increases by 1.6 times with every additional millimetre of initial residual bone height. Conflict-of-interest statement: All authors declare that they have neither financial nor non-financial competing interests.
M3 - SCORING: Journal article
C2 - 27722225
VL - 9
SP - 277
EP - 289
JO - EUR J ORAL IMPLANTOL
JF - EUR J ORAL IMPLANTOL
SN - 1756-2406
IS - 3
ER -